Shanghai Pharmaceuticals Holding Co., Ltd Share Price Other OTC
Stocks
SHPMY
US81943R1005
Pharmaceuticals
OTC Markets Traded| Market Cap | 5.58TCr 823.51Cr 719.66Cr 665.28Cr 614.64Cr 1.16TCr 79TCr 1.18TCr 7.93TCr 3.11TCr 39TCr 3.09TCr 3.02TCr 1,33400Cr | P/E 2026 * |
11.5x | P/E 2027 * | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 6.04TCr 892.46Cr 779.92Cr 720.99Cr 666.11Cr 1.25TCr 86TCr 1.28TCr 8.6TCr 3.37TCr 42TCr 3.35TCr 3.28TCr 1,44500Cr | EV / Sales 2026 * |
0.2x | EV / Sales 2027 * | 0.22x |
| Free-Float |
41.21% | Yield 2026 * |
2.61% | Yield 2027 * | 2.87% |
| 1 day | -3.18% |
| Manager | Title | Age | Since |
|---|---|---|---|
Yong Zhong Li
PSD | President | 56 | 29/06/2023 |
Bo Shen
DFI | Director of Finance/CFO | 53 | 05/06/2013 |
Xue Jun Cai
CTO | Chief Tech/Sci/R&D Officer | 63 | 01/10/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Shen
BRD | Director/Board Member | 53 | 28/06/2016 |
Yong Zhong Li
BRD | Director/Board Member | 56 | 27/06/2019 |
You Li Xu
CHM | Chairman | 51 | 29/06/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.18% | +4.04% | - | - | 809.78Cr | |
| -0.89% | -0.42% | +12.35% | +96.33% | 9.51TCr | |
| -2.06% | -4.55% | +41.51% | +145.66% | 5.47TCr | |
| 0.00% | +3.55% | +2.10% | +269.62% | 2.33TCr | |
| +2.67% | -1.64% | -25.39% | -33.86% | 754.21Cr | |
| +0.95% | -1.33% | -9.71% | -27.31% | 670.85Cr | |
| -1.00% | -5.39% | +19.72% | +30.60% | 615.55Cr | |
| -0.46% | +0.46% | -2.14% | +22.35% | 536.36Cr | |
| +2.96% | +3.17% | -2.43% | -3.99% | 372.12Cr | |
| +0.51% | -0.96% | +12.82% | +17.15% | 335.57Cr | |
| Average | -0.04% | +0.94% | +5.43% | +57.39% | 2.29TCr | |
| Weighted average by Cap. | -0.89% | +1.77% | +16.42% | +113.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 30TCr 4.39TCr 3.84TCr 3.55TCr 3.28TCr 6.17TCr 4,21600Cr 6.28TCr 42TCr 17TCr 2,06400Cr 16TCr 16TCr 7,10800Cr | 32TCr 4.65TCr 4.07TCr 3.76TCr 3.47TCr 6.54TCr 4,47100Cr 6.66TCr 45TCr 18TCr 2,18900Cr 17TCr 17TCr 7,53800Cr |
| Net income | 534.52Cr 79Cr 69Cr 64Cr 59Cr 110.93Cr 7.58TCr 112.93Cr 760.32Cr 298.31Cr 3.71TCr 296.44Cr 289.89Cr 13TCr | 560.24Cr 83Cr 72Cr 67Cr 62Cr 116.26Cr 7.95TCr 118.37Cr 796.9Cr 312.66Cr 3.89TCr 310.7Cr 303.84Cr 13TCr |
| Net Debt | 467.05Cr 69Cr 60Cr 56Cr 51Cr 97Cr 6.62TCr 99Cr 664.35Cr 260.66Cr 3.24TCr 259.02Cr 253.3Cr 11TCr | 1.27TCr 187.02Cr 163.43Cr 151.08Cr 139.58Cr 262.86Cr 18TCr 267.62Cr 1.8TCr 706.91Cr 8.8TCr 702.47Cr 686.95Cr 30TCr |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Choose MarketScreener 
